One-compound-multi-targets at amyloid β cascade offered by Bis(7)-Cognitin, a novel anti-Alzheimer's dimer

Wenming Li, Hongjun Fu, Moussa B H Youdim, Yuan-Ping Pang, Yifan Han

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Alzheimer's disease (AD) is a progressive, degenerative disorder of the brain and the most common form of dementia among the elderly. The neuropathological hallmarks of AD are senile plaques, which are extracellular deposits predominantly composed of fibrillar amyloid β peptide (Aβ), and intracellular neurofibrillary tangles composed of filamentous aggregates called paired helical filaments of hyperphosphorylated tau protein. Aβ is proposed to play a key role in the pathogenesis of AD. Therefore, treatments targeting the biosynthesis, oligomerization/aggregation, and toxicity of Aβ are likely to be the promising disease-modifying therapeutics. Bis(7)-Cognitin, one of our promising anti-Alzheimer's dimers, has previously been shown to possess potent acetylcholinesterase (AChE) inhibition, memory-enhancement, and neuroprotection against several stimuli that go beyond the inhibition of AChE. Our recent studies have further demonstrated that bis(7)-Cognitin exerts profound neuroprotective effects by targeting the multiple stages of the Aβ pathological cascade of AD, i.e. the biosynthesis, oligomerization/aggregation and toxicity of Aβ. These findings may offer not only a new and clinically significant modality as to how the agent exerts neuroprotective effects, but also a novel direction to rationally develop one-compound-multi-targets drugs for the prevention and treatment of AD, even of other neurodegenerative diseases.

Original languageEnglish (US)
Title of host publicationBrain Protection in Schizophrenia, Mood and Cognitive Disorders
PublisherSpringer Netherlands
Pages165-183
Number of pages19
ISBN (Print)9789048185535, 9789048185528
DOIs
StatePublished - 2010

Fingerprint

Amyloid
Alzheimer Disease
Neuroprotective Agents
Acetylcholinesterase
tau Proteins
Neurofibrillary Tangles
Amyloid Plaques
Brain Diseases
Neurodegenerative Diseases
Dementia
Therapeutics
1,7-N-heptylene-bis-9,9'-amino-1,2,3,4-tetrahydroacridine
Pharmaceutical Preparations
Inhibition (Psychology)

Keywords

  • Alzheimer's disease
  • APP processing
  • Bis(7)-Cognitin
  • Disease modification

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Li, W., Fu, H., Youdim, M. B. H., Pang, Y-P., & Han, Y. (2010). One-compound-multi-targets at amyloid β cascade offered by Bis(7)-Cognitin, a novel anti-Alzheimer's dimer. In Brain Protection in Schizophrenia, Mood and Cognitive Disorders (pp. 165-183). Springer Netherlands. https://doi.org/10.1007/978-90-481-8553-5_7

One-compound-multi-targets at amyloid β cascade offered by Bis(7)-Cognitin, a novel anti-Alzheimer's dimer. / Li, Wenming; Fu, Hongjun; Youdim, Moussa B H; Pang, Yuan-Ping; Han, Yifan.

Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Springer Netherlands, 2010. p. 165-183.

Research output: Chapter in Book/Report/Conference proceedingChapter

Li, W, Fu, H, Youdim, MBH, Pang, Y-P & Han, Y 2010, One-compound-multi-targets at amyloid β cascade offered by Bis(7)-Cognitin, a novel anti-Alzheimer's dimer. in Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Springer Netherlands, pp. 165-183. https://doi.org/10.1007/978-90-481-8553-5_7
Li W, Fu H, Youdim MBH, Pang Y-P, Han Y. One-compound-multi-targets at amyloid β cascade offered by Bis(7)-Cognitin, a novel anti-Alzheimer's dimer. In Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Springer Netherlands. 2010. p. 165-183 https://doi.org/10.1007/978-90-481-8553-5_7
Li, Wenming ; Fu, Hongjun ; Youdim, Moussa B H ; Pang, Yuan-Ping ; Han, Yifan. / One-compound-multi-targets at amyloid β cascade offered by Bis(7)-Cognitin, a novel anti-Alzheimer's dimer. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Springer Netherlands, 2010. pp. 165-183
@inbook{8a49844949b24ec4bc8098fb76138348,
title = "One-compound-multi-targets at amyloid β cascade offered by Bis(7)-Cognitin, a novel anti-Alzheimer's dimer",
abstract = "Alzheimer's disease (AD) is a progressive, degenerative disorder of the brain and the most common form of dementia among the elderly. The neuropathological hallmarks of AD are senile plaques, which are extracellular deposits predominantly composed of fibrillar amyloid β peptide (Aβ), and intracellular neurofibrillary tangles composed of filamentous aggregates called paired helical filaments of hyperphosphorylated tau protein. Aβ is proposed to play a key role in the pathogenesis of AD. Therefore, treatments targeting the biosynthesis, oligomerization/aggregation, and toxicity of Aβ are likely to be the promising disease-modifying therapeutics. Bis(7)-Cognitin, one of our promising anti-Alzheimer's dimers, has previously been shown to possess potent acetylcholinesterase (AChE) inhibition, memory-enhancement, and neuroprotection against several stimuli that go beyond the inhibition of AChE. Our recent studies have further demonstrated that bis(7)-Cognitin exerts profound neuroprotective effects by targeting the multiple stages of the Aβ pathological cascade of AD, i.e. the biosynthesis, oligomerization/aggregation and toxicity of Aβ. These findings may offer not only a new and clinically significant modality as to how the agent exerts neuroprotective effects, but also a novel direction to rationally develop one-compound-multi-targets drugs for the prevention and treatment of AD, even of other neurodegenerative diseases.",
keywords = "Alzheimer's disease, APP processing, Aβ, Bis(7)-Cognitin, Disease modification",
author = "Wenming Li and Hongjun Fu and Youdim, {Moussa B H} and Yuan-Ping Pang and Yifan Han",
year = "2010",
doi = "10.1007/978-90-481-8553-5_7",
language = "English (US)",
isbn = "9789048185535",
pages = "165--183",
booktitle = "Brain Protection in Schizophrenia, Mood and Cognitive Disorders",
publisher = "Springer Netherlands",

}

TY - CHAP

T1 - One-compound-multi-targets at amyloid β cascade offered by Bis(7)-Cognitin, a novel anti-Alzheimer's dimer

AU - Li, Wenming

AU - Fu, Hongjun

AU - Youdim, Moussa B H

AU - Pang, Yuan-Ping

AU - Han, Yifan

PY - 2010

Y1 - 2010

N2 - Alzheimer's disease (AD) is a progressive, degenerative disorder of the brain and the most common form of dementia among the elderly. The neuropathological hallmarks of AD are senile plaques, which are extracellular deposits predominantly composed of fibrillar amyloid β peptide (Aβ), and intracellular neurofibrillary tangles composed of filamentous aggregates called paired helical filaments of hyperphosphorylated tau protein. Aβ is proposed to play a key role in the pathogenesis of AD. Therefore, treatments targeting the biosynthesis, oligomerization/aggregation, and toxicity of Aβ are likely to be the promising disease-modifying therapeutics. Bis(7)-Cognitin, one of our promising anti-Alzheimer's dimers, has previously been shown to possess potent acetylcholinesterase (AChE) inhibition, memory-enhancement, and neuroprotection against several stimuli that go beyond the inhibition of AChE. Our recent studies have further demonstrated that bis(7)-Cognitin exerts profound neuroprotective effects by targeting the multiple stages of the Aβ pathological cascade of AD, i.e. the biosynthesis, oligomerization/aggregation and toxicity of Aβ. These findings may offer not only a new and clinically significant modality as to how the agent exerts neuroprotective effects, but also a novel direction to rationally develop one-compound-multi-targets drugs for the prevention and treatment of AD, even of other neurodegenerative diseases.

AB - Alzheimer's disease (AD) is a progressive, degenerative disorder of the brain and the most common form of dementia among the elderly. The neuropathological hallmarks of AD are senile plaques, which are extracellular deposits predominantly composed of fibrillar amyloid β peptide (Aβ), and intracellular neurofibrillary tangles composed of filamentous aggregates called paired helical filaments of hyperphosphorylated tau protein. Aβ is proposed to play a key role in the pathogenesis of AD. Therefore, treatments targeting the biosynthesis, oligomerization/aggregation, and toxicity of Aβ are likely to be the promising disease-modifying therapeutics. Bis(7)-Cognitin, one of our promising anti-Alzheimer's dimers, has previously been shown to possess potent acetylcholinesterase (AChE) inhibition, memory-enhancement, and neuroprotection against several stimuli that go beyond the inhibition of AChE. Our recent studies have further demonstrated that bis(7)-Cognitin exerts profound neuroprotective effects by targeting the multiple stages of the Aβ pathological cascade of AD, i.e. the biosynthesis, oligomerization/aggregation and toxicity of Aβ. These findings may offer not only a new and clinically significant modality as to how the agent exerts neuroprotective effects, but also a novel direction to rationally develop one-compound-multi-targets drugs for the prevention and treatment of AD, even of other neurodegenerative diseases.

KW - Alzheimer's disease

KW - APP processing

KW - Aβ

KW - Bis(7)-Cognitin

KW - Disease modification

UR - http://www.scopus.com/inward/record.url?scp=84919594839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919594839&partnerID=8YFLogxK

U2 - 10.1007/978-90-481-8553-5_7

DO - 10.1007/978-90-481-8553-5_7

M3 - Chapter

SN - 9789048185535

SN - 9789048185528

SP - 165

EP - 183

BT - Brain Protection in Schizophrenia, Mood and Cognitive Disorders

PB - Springer Netherlands

ER -